Causey Carey 4

What Happened

• Causey Carey, Ball Corporation’s Senior Vice President & Chief Growth Officer, was granted equity awards on 2026-02-19. The filing shows 5,956 derivative units that convert one-for-one into common shares and 15,595 restricted stock units (RSUs) granted at $0 cost.
• These were grants/awards (code A), not open-market purchases or sales. The RSUs are subject to vesting (see Key Details). No cash was paid by the insider to acquire these awards.

Key Details

• Transaction date: 2026-02-19; Form 4 filed 2026-02-23 (timely within the required 2 business days).
• Grants: 5,956 convertible units (convertible one-for-one into common stock per footnote F1) and 15,595 RSUs granted at $0.00 (footnote F2).
• Vesting and terms: RSUs vest on the third anniversary of the award date, generally subject to continued employment (F2). Footnotes also describe non‑qualified stock option terms (vesting ~4 years and up to 10‑year expiration) for related grants under the company plan (F4–F6).
• Shares owned after the transactions: not specified in the provided excerpt.
• Transaction type: Award/Grant (A). No sale or purchase reported in this filing.

Context

• Awards and RSUs are a common form of executive compensation and do not represent an open‑market purchase (so they’re not a direct bullish signal in the way a personal buy would be).
• The convertible units convert to common shares without cost on a one‑for‑one basis when they convert; RSUs convert to shares upon vesting subject to the plan terms and continued employment.
• If you track insider activity for signals, purchases matter more than routine compensation grants, but grants can still be useful to monitor for dilution and future share delivery.